Lexington VA Medical Center - Cooper Division ( Site 0137) — Lexington, Kentucky

Lexington VA Medical Center - Cooper Division ( Site 0137) is a clinical research site located in Lexington, Kentucky, United States 40502.

Crixeo Clinical Trials Trust Score: 95/100 (GOOD). This profile has not yet been claimed by the site owner.

Lexington VA Medical Center - Cooper Division ( Site 0137) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lexington

Browse all research sites in Kentucky · View every site in Lexington

Sponsor Feasibility Report

Trust Score: 95/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lexington VA Medical Center - Cooper Division ( Site 0137)?

Lexington VA Medical Center - Cooper Division ( Site 0137) has a Crixeo Trust Score of 95/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lexington VA Medical Center - Cooper Division ( Site 0137) conducted?

Lexington VA Medical Center - Cooper Division ( Site 0137) has 1 clinical trials on record, with 1 currently active. Their work covers Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease.

Is Lexington VA Medical Center - Cooper Division ( Site 0137) accredited by Crixeo Clinical Trials?

Lexington VA Medical Center - Cooper Division ( Site 0137) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lexington VA Medical Center - Cooper Division ( Site 0137)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.